The global cochlear implants market reached a value of US$ 2.5 Billion in 2018. A cochlear implant is an electronic device that is surgically placed in the ears for producing useful hearing sensations. It is implanted in the inner ear of individuals with severe to profound nerve deafness. The device consists of a microphone, speech processor, transmitter and an electrode array. It electrically stimulates nerves and transforms sound vibrations into signals that are sent to the auditory nerve. The signals are then sent to the brain and get translated to recognizable sounds. The implant does not restore normal hearing capabilities; instead, it provides a representation of environmental sounds and assists the individual to interpret or understand them as speech.
The growing geriatric population, along with the increasing incidence of children born with hearing defects, is one of the key factors driving the market growth. Furthermore, medical breakthroughs have enabled early diagnosis of otic diseases and related ear disorders. This, coupled with the rising awareness regarding the benefits of hearing aids, has significantly propelled their adoption rate among the masses. The product innovations are also representing as another major growth-inducing factor. Manufacturers are attempting to launch more user-friendly and efficient product variants in the market. For instance, the introduction of waterproof and rechargeable cochlear implants, along with the integration of next-generation sound processors, has notably boosted the product sales. Moreover, efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all have also proven to be pivotal to the market growth. Other growth-inducing factors include rising disposable incomes, increasing healthcare expenditures and enhanced research and development (R&D) activities. Looking forward, IMARC Group expects the market to reach a value of US$ 4.4 Billion by 2024, registering a CAGR of around 10% during 2019-2024.
The report has also analyzed the competitive landscape of the market with some of the key players being Cochlear Ltd., MED-EL, Advanced Bionics Corporation, William Demant, Nurotron Biotechnology Ltd., Oticon Medical, Sonova, etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at